Natriuresis-guided diuretic therapy improves decongestion in acute heart failure

A pragmatic natriuresis-guided diuretic approach in patients with acute heart failure significantly increases 24-hour natriuresis without impacting all-cause mortality or heart failure rehospitalization, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

The 9th Joint ECTRIMS-ACTRIMS Meeting – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Study results/Conference 11.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Presents

October 12, 2023

WHO recommends a comprehensive set of tobacco cessation interventions

The World Health Organization (WHO) recommends a comprehensive set of tobacco cessation interventions, including behavioral support delivered by health-care providers, digital cessation interventions and pharmacological

July 2, 2024

Air pollution affects the heart at surprisingly low levels, but diet may offer protection

Exposure to air pollutants, even at very low concentrations, was associated with adverse changes in cardiometabolic risk factors in a recent Finnish study

January 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.